For the vast majority of people, modern PrEP medications are well-tolerated and not considered overly harsh on the body. Clinical studies confirm that current formulations have favorable safety profiles with minimal long-term health complications. However, because the medications are processed through the kidneys and liver, doctors monitor patients via routine blood tests every three months to ensure renal function remains stable. A small percentage of users may experience mild, short-term gastrointestinal discomfort when first introducing the drug, but severe adverse reactions are rare and carefully managed by prescribing physicians.
1 votes
Marked as accepted